Management of INR 3.6 with Target Range 2.5-3.5
For an INR of 3.6 with a target range of 2.5-3.5, you should continue your current warfarin dose without any adjustment and recheck the INR within 1-2 weeks.
Rationale
Your INR is only 0.1 units above your therapeutic range, which qualifies as a single, minimally out-of-range value. The most recent and highest-quality evidence directly addresses this scenario:
Evidence-Based Approach
The 2012 American College of Chest Physicians (ACCP) guidelines specifically recommend that for patients with previously stable therapeutic INRs who present with a single out-of-range INR of 0.5 below or above therapeutic, continue the current dose and test the INR within 1-2 weeks 1.
This recommendation is supported by:
Randomized controlled trial data showing no significant difference in outcomes between dose adjustment versus no adjustment for INRs between 1.5-4.4 (including your target range of 2.5-3.5). At 2-week follow-up, 44% remained out of range with dose changes versus 40% with no changes—essentially equivalent outcomes 1.
Observational data from 3,961 patients suggesting warfarin doses do not need adjustment for INRs between 1.7-3.3, which encompasses your situation 1.
Recent 2022 research confirming that watchful waiting versus dose changes for slightly out-of-range INRs showed minimal clinical difference (58.9% vs 60.0% back in range, p=0.024)—a statistically significant but clinically insignificant difference 2.
When You WOULD Need to Act
According to the 2003 AHA/ACC guidelines, intervention is only warranted when 3:
- INR is above 5.0 without bleeding: Omit 1-2 doses, restart at lower dose when INR approaches therapeutic range
- INR 5-9 with bleeding risk factors: Omit next dose AND give oral vitamin K 1-2.5 mg
- INR >9: Give oral vitamin K 3-5 mg regardless of bleeding
Your INR of 3.6 falls well below these thresholds.
Critical Monitoring Points
- Recheck INR in 1-2 weeks to ensure this was an isolated elevation and not a progressive trend 1
- Look for temporary causes: dietary vitamin K changes, new medications, illness, alcohol intake
- Do not make dose adjustments >20% if you do eventually need to adjust, as this causes excessive INR drops 4
Common Pitfalls to Avoid
- Over-correction: Making dose changes for minimal INR elevations leads to INR instability without improving outcomes
- Vitamin K administration: Completely unnecessary at this level; reserved for INR ≥5
- Panic: The absolute daily bleeding risk remains low even with INRs up to 5.0 in patients without active bleeding 3
Your bleeding risk at INR 3.6 is not meaningfully different from INR 3.5, and unnecessary dose adjustments will likely cause more INR variability than benefit.